GABA-containing liposomes: neuroscience applications and translational perspectives for targeting neurological diseases

Marco Antônio Peliky Fontes, Gisele Cristiane Vaz, Thais Zielke Dias Cardoso, Mariana Flávia de Oliveira, Maria José Campagnole-Santos, Robson Augusto Souza dos Santos, Neeru M. Sharma, Kaushik P. Patel, Frédéric Frézard

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

There are multiple challenges for neuropharmacology in the future. Undoubtedly, one of the greatest challenges is the development of strategies for pharmacological targeting of specific brain regions for treatment of diseases. GABA is the main inhibitory neurotransmitter in the central nervous system, and dysfunction of GABAergic mechanisms is associated with different neurological conditions. Liposomes are lipid vesicles that are able to encapsulate chemical compounds and are used for chronic drug delivery. This short review reports our experience with the development of liposomes for encapsulation and chronic delivery of GABA to sites within the brain. Directions for future research regarding the efficacy and practical use of GABA-containing liposomes for extended periods of time as well as understanding and targeting neurological conditions are discussed.

Original languageEnglish (US)
Pages (from-to)781-788
Number of pages8
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume14
Issue number3
DOIs
StatePublished - Apr 2018

Fingerprint

Liposomes
Neurosciences
gamma-Aminobutyric Acid
Brain
Neuropharmacology
Chemical compounds
Neurology
Drug delivery
Encapsulation
Lipids
Neurotransmitter Agents
Central Nervous System
Pharmacology
Pharmaceutical Preparations
Therapeutics

Keywords

  • GABA
  • Liposomes
  • Nervous system
  • Neurological diseases
  • Neuroscience

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Fontes, M. A. P., Vaz, G. C., Cardoso, T. Z. D., de Oliveira, M. F., Campagnole-Santos, M. J., dos Santos, R. A. S., ... Frézard, F. (2018). GABA-containing liposomes: neuroscience applications and translational perspectives for targeting neurological diseases. Nanomedicine: Nanotechnology, Biology, and Medicine, 14(3), 781-788. https://doi.org/10.1016/j.nano.2017.12.007

GABA-containing liposomes : neuroscience applications and translational perspectives for targeting neurological diseases. / Fontes, Marco Antônio Peliky; Vaz, Gisele Cristiane; Cardoso, Thais Zielke Dias; de Oliveira, Mariana Flávia; Campagnole-Santos, Maria José; dos Santos, Robson Augusto Souza; Sharma, Neeru M.; Patel, Kaushik P.; Frézard, Frédéric.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 14, No. 3, 04.2018, p. 781-788.

Research output: Contribution to journalReview article

Fontes, MAP, Vaz, GC, Cardoso, TZD, de Oliveira, MF, Campagnole-Santos, MJ, dos Santos, RAS, Sharma, NM, Patel, KP & Frézard, F 2018, 'GABA-containing liposomes: neuroscience applications and translational perspectives for targeting neurological diseases', Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 14, no. 3, pp. 781-788. https://doi.org/10.1016/j.nano.2017.12.007
Fontes, Marco Antônio Peliky ; Vaz, Gisele Cristiane ; Cardoso, Thais Zielke Dias ; de Oliveira, Mariana Flávia ; Campagnole-Santos, Maria José ; dos Santos, Robson Augusto Souza ; Sharma, Neeru M. ; Patel, Kaushik P. ; Frézard, Frédéric. / GABA-containing liposomes : neuroscience applications and translational perspectives for targeting neurological diseases. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2018 ; Vol. 14, No. 3. pp. 781-788.
@article{261e63725cfc4ab8b965470ad45f9969,
title = "GABA-containing liposomes: neuroscience applications and translational perspectives for targeting neurological diseases",
abstract = "There are multiple challenges for neuropharmacology in the future. Undoubtedly, one of the greatest challenges is the development of strategies for pharmacological targeting of specific brain regions for treatment of diseases. GABA is the main inhibitory neurotransmitter in the central nervous system, and dysfunction of GABAergic mechanisms is associated with different neurological conditions. Liposomes are lipid vesicles that are able to encapsulate chemical compounds and are used for chronic drug delivery. This short review reports our experience with the development of liposomes for encapsulation and chronic delivery of GABA to sites within the brain. Directions for future research regarding the efficacy and practical use of GABA-containing liposomes for extended periods of time as well as understanding and targeting neurological conditions are discussed.",
keywords = "GABA, Liposomes, Nervous system, Neurological diseases, Neuroscience",
author = "Fontes, {Marco Ant{\^o}nio Peliky} and Vaz, {Gisele Cristiane} and Cardoso, {Thais Zielke Dias} and {de Oliveira}, {Mariana Fl{\'a}via} and Campagnole-Santos, {Maria Jos{\'e}} and {dos Santos}, {Robson Augusto Souza} and Sharma, {Neeru M.} and Patel, {Kaushik P.} and Fr{\'e}d{\'e}ric Fr{\'e}zard",
year = "2018",
month = "4",
doi = "10.1016/j.nano.2017.12.007",
language = "English (US)",
volume = "14",
pages = "781--788",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - GABA-containing liposomes

T2 - neuroscience applications and translational perspectives for targeting neurological diseases

AU - Fontes, Marco Antônio Peliky

AU - Vaz, Gisele Cristiane

AU - Cardoso, Thais Zielke Dias

AU - de Oliveira, Mariana Flávia

AU - Campagnole-Santos, Maria José

AU - dos Santos, Robson Augusto Souza

AU - Sharma, Neeru M.

AU - Patel, Kaushik P.

AU - Frézard, Frédéric

PY - 2018/4

Y1 - 2018/4

N2 - There are multiple challenges for neuropharmacology in the future. Undoubtedly, one of the greatest challenges is the development of strategies for pharmacological targeting of specific brain regions for treatment of diseases. GABA is the main inhibitory neurotransmitter in the central nervous system, and dysfunction of GABAergic mechanisms is associated with different neurological conditions. Liposomes are lipid vesicles that are able to encapsulate chemical compounds and are used for chronic drug delivery. This short review reports our experience with the development of liposomes for encapsulation and chronic delivery of GABA to sites within the brain. Directions for future research regarding the efficacy and practical use of GABA-containing liposomes for extended periods of time as well as understanding and targeting neurological conditions are discussed.

AB - There are multiple challenges for neuropharmacology in the future. Undoubtedly, one of the greatest challenges is the development of strategies for pharmacological targeting of specific brain regions for treatment of diseases. GABA is the main inhibitory neurotransmitter in the central nervous system, and dysfunction of GABAergic mechanisms is associated with different neurological conditions. Liposomes are lipid vesicles that are able to encapsulate chemical compounds and are used for chronic drug delivery. This short review reports our experience with the development of liposomes for encapsulation and chronic delivery of GABA to sites within the brain. Directions for future research regarding the efficacy and practical use of GABA-containing liposomes for extended periods of time as well as understanding and targeting neurological conditions are discussed.

KW - GABA

KW - Liposomes

KW - Nervous system

KW - Neurological diseases

KW - Neuroscience

UR - http://www.scopus.com/inward/record.url?scp=85041857318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041857318&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2017.12.007

DO - 10.1016/j.nano.2017.12.007

M3 - Review article

C2 - 29278747

AN - SCOPUS:85041857318

VL - 14

SP - 781

EP - 788

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 3

ER -